220 studies found for:    "Diabetic Nephropathies"
Show Display Options
RSS Create an RSS feed from your search for:
"Diabetic Nephropathies"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Enrolling by invitation Mechanisms of Diabetic Nephropathy in Ecuador
Conditions: Diabetic Nephropathy;   Diabetes Mellitus;   Kidney Diseases;   Diabetic Kidney Disease;   Chronic Kidney Disease
Intervention:
2 Completed A Study in Patients With Diabetic Kidney Disease
Conditions: Diabetic Kidney Disease;   Diabetic Nephropathy;   Diabetic Glomerulosclerosis
Interventions: Drug: LY2382770;   Drug: Placebo
3 Completed Spironolactone in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Spironolactone
4 Active, not recruiting Minocycline and Proteinuria in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Minocycline 100 mg po bid for 6 months;   Drug: placebo
5 Completed Soy Protein in Early Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Diabetes Mellitus
Intervention: Drug: soy protein
6 Recruiting Glutathione in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Proteinuria;   Oxidative Stress
Interventions: Drug: N-acetylcysteine placebo + silibin placebo;   Drug: N-acetylcysteine active + silibin placebo;   Drug: N-acetylcysteine placebo + silibin active;   Drug: N-acetylcysteine active + silibin active;   Drug: N-acetylcysteine active + high-dose silibin active
7 Recruiting Renal Denervation in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Persistent Proteinuria With Type II Diabetes
Interventions: Procedure: Percutaneous renal denervation and TMNS;   Drug: Standardized antiproteinuric medication regimen includes an angiotensin receptor blocker , a diuretic , 25OH vitamin D3 and a statin
8 Completed Spironolactone for Reducing Proteinuria in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: spironolactone
9 Terminated Effect of Sulodexide in Overt Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Sulodexide
10 Completed Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Chronic Kidney Disease;   Diabetes Type 2
Intervention: Drug: N-acetylcysteine
11 Unknown  Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration
Conditions: Diabetic Nephropathy;   Chronic Kidney Disease
Intervention: Drug: Mycophenolate Mofetil (MMF) ,phosphodiesterase 5 inhibitors , CARNITINE
12 Recruiting N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy
Conditions: Diabetic Nephropathies;   Proteinuria;   Oxidative Stress
Interventions: Dietary Supplement: N-acetylcysteine;   Dietary Supplement: silibin;   Dietary Supplement: high-dose silibin;   Dietary Supplement: N-acetylcysteine placebo;   Dietary Supplement: silibin placebo
13 Completed Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Sevelamer Carbonate;   Drug: Calcium Carbonate
14 Not yet recruiting The Significance of Urine UbA52 In the Diagnosis of Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention:
15 Completed Adiponectin and Insulin Resistance in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Losartan
16 Completed Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy
Conditions: Albuminuria;   Diabetic Nephropathy
Intervention: Drug: XL784
17 Completed Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting.
Conditions: Chronic Kidney Disease;   Diabetic Nephropathy
Intervention: Behavioral: Community-based Integrated CKD Care
18 Active, not recruiting Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: MT-3995-Low;   Drug: MT-3995-High;   Drug: Placebo
19 Completed Combined Diabetes-Renal Multifactorial Intervention In Patients With Advanced Diabetic Nephropathy (ADN)
Condition: Diabetic Nephropathy
Intervention: Other: Multifactorial Intervention
20 Recruiting Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients
Condition: Diabetic Nephropathy
Interventions: Drug: Repository Corticotropin Injection;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years